Biofilm-Grown Burkholderia cepacia Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Van Acker, Heleen ^a   Sass, Andrea ^a   Bazzini, Silvia ^b   De Roy, Karen ^a   Udine, Claudia ^b   Messiaen, Thomas ^a   Riccardi, Giovanna ^b   Boon, Nico ^a   Nelis, Hans J ^a   Mahenthiralingam, Eshwar ^c   Coenye, Tom ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF PAVIA   (Italy)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CATALASE; GLYOXYLIC ACID; ISOCITRATE LYASE; ITACONIC ACID; REACTIVE OXYGEN METABOLITE; TOBRAMYCIN; TRANSCRIPTOME; TRICARBOXYLIC ACID;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BIOFILM; BURKHOLDERIA CEPACIA; CELL LINEAGE; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ELECTRON TRANSPORT; FLOW CYTOMETRY; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENETIC ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DYNAMICS; NONHUMAN; PHENOTYPE; SIGNAL TRANSDUCTION; UPREGULATION;

ANTI-BACTERIAL AGENTS; BIOFILMS; BURKHOLDERIA CEPACIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; REACTIVE OXYGEN SPECIES; TOBRAMYCIN;

EID: 84874847175     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058943     Document Type: Article

References (34)

1. Vanlaere E, Baldwin A, Gevers D, Henry D, De Brandt E, et al. (2009) Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp.nov. Int J Syst Evol Microbiol 59: 102-111.
2. LiPuma JJ, (2005) Update on the Burkholderia cepacia complex. Curr Opin Pulm Med 11: 528-533.
3. Jones AM, Dodd ME, Govan JRW, Barcus V, Doherty CJ, et al. (2004) Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax 59: 948-951.
4. De Soyza A, Morris K, McDowell A, Doherty C, Archer L, et al. (2004) Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation. Thorax 59: 526-528.
5. Mahenthiralingam E, Urban TA, Goldberg JB, (2005) The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 3: 144-156.
6. Donlan RM, Costerton JW, (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193.
7. Caraher E, Reynolds G, Murphy P, McClean S, Callaghan M, (2006) Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro. Eur J Clin Microbiol Infect Dis 26: 213-216.
8. Lewis K, (2001) Riddle of biofilm resistance. Antimicrob Agents Chemother 45: 999-1007.
9. Mah TFC, O'Toole GA, (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9: 34-39.
10. George AM, Jones PM, Middleton PG, (2009) Cystic fibrosis infections: treatment strategies and prospects. FEMS Microbiol Lett 300: 153-164.
11. Lewis K, (2010) Persister cells. Annu. Rev. Microbiol 64: 357-372.
12. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K, (2004) Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. FEMS Microbiol. Lett. 230: 13-18.
13. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ, (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130: 797-810.
14. Berg JM, Tymoczko JL, Stryer L (2002) Biochemistry. 5th edition. New York: WH Freeman. Section 17.4.
15. Van Schaik EJ, Tom M, Woods DE, (2009) Burkholderia pseudomallei isocitrate lyase is a persistence factor in pulmonary melioidosis: implications for the development of isocitrate lyase inhibitors as novel antimicrobials. Infection and immunity 77: 4275-4283.
16. Lefebre MD, Flannagan RS, Valvano MA, (2005) A minor catalase/peroxidase from Burkholderia cenocepacia is required for normal aconitase activity. Microbiol 151: 1975-1985.
17. LiPuma JJ, Spiker T, Coenye T, Gonzalez CF, (2002) An epidemic Burkholderia cepacia complex strain identified in soil. Lancet 359: 2002-2003.
18. Peeters E, Nelis HJ, Coenye T, (2009) In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria. J Antimicrob Chemother 64: 801-809.
19. Van Acker H, Van Snick E, Nelis HJ, Coenye T, (2010) In vitro activity of temocillin against planktonic and sessile Burkholderia cepacia complex bacteria. J Cyst Fibros 9: 450-454.
20. Peeters E, Sass A, Mahenthiralingam E, Nelis H, Coenye T, (2010) Transcriptional response of Burkholderia cenocepacia J2315 sessile cells to treatments with high doses of H2O2 and NaOCl. BMC Genomics 11: 90.
21. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 3: 1-11.
22. Hamad MA, Skeldon AM, Valvano MA, (2010) Construction of aminoglycoside-sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamycin protection assay. Appl. Environ. Microbiol 76: 3170-3176.
23. Cardona ST, Mueller CL, Valvano MA, (2006) Identification of essential operons with a rhamnose-inducible promotor in Burkholderia cenocepacia App Environ Microbiol. 72: 2547-2555.
24. Sambrook J, Fritsch EF, Maniatis T (1990) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory.
25. Cohen SN, Chang AC, Hsu L, (1972) Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA. Proc. Natl. Acad. Sci. USA 69: 2110-2114.
26. Craig FF, Coote JG, Parton R, Freer JH, Gilmour NJ, (1989) A plasmid which can be transferred between Escherichia coli and Pasteurella haemolytica by electroporation and conjugation. J. Gen. Microbiol. 135: 2885-2890.
27. Figurski DH, Helinski DR, (1979) Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans Proc. Natl. Acad. Sci. USA 76: 1648-1652.
28. Mulcahy LR, Burns JL, Lory S, Lewis K, (2010) Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol 192: 6191-6199.
29. Young JP, Crossman LC, Johnston AW, Thomson NR, Ghazoui ZF, et al. (2006) The genome of Rhizobium leguminosarum has recognizable core and accessory components. Genome Biol 7: R34.
30. Riley M, (1993) Functions of the gene products of Escherichia coli. Microbiol Rev 57: 862-952.
31. Sing R, Lemire J, Mailloux RJ, Chénier D, Hamel R, Appanna VD, (2009) An ATP and oxalate generating variant tricarboxylic acid cycle counters aluminium toxicity in Pseudomonas fluorescens. Plos One 4: e7344.
32. Hagins JM, Scoffield JA, Suh SJ, Silo-Suh L, (2010) Influence of RpoN on isocitrate lyase activity in Pseudomonas aeruginosa. Microbiology 156: 1201-1210.
33. Alston TA, Mela L, Bright HJ, (1977) 3-nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase Proc Natl Acad Sci USA. 74: 3767-3771.
34. Allison K, Brynildsen M, Collins J, (2011) Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473: 216-220.